PlainRecalls
FDA Drug Moderate Class II Terminated

HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2011-1

Reported: October 11, 2023 Initiated: September 21, 2023 #D-0029-2024

Product Description

HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2011-1

Reason for Recall

Lack of assurance of sterility:

Details

Units Affected
4,550 30 mL syringes
Distribution
Nationwide in the USA
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2011-1. Recalled by Central Admixture Pharmacy Services Inc. Units affected: 4,550 30 mL syringes.
Why was this product recalled?
Lack of assurance of sterility:
Which agency issued this recall?
This recall was issued by the FDA Drug on October 11, 2023. Severity: Moderate. Recall number: D-0029-2024.